세계의 감염 예방 및 관리 시장 : 시장 인사이트, 경쟁 구도, 시장 예측(2030년)

Infection Prevention And Control Market By Product (Equipment [Sterilization Equipment {Heat Sterilization Equipment, Low-Temperature Sterilization Equipment, Radiation Sterilization, And Others} And Disinfectors {Washers, Flushes, Endoscope Reprocessors, And Others}] And Consumables [Disinfectants {Hand Disinfectants, Surface Disinfectants, Skin Disinfectants, And Others}, Personal Protective Equipment {Surgical Drapes, Surgical Gowns, Gloves, And Others}, Sterilization Consumables, Infectious Waste Disposal, And Others]), End-User (Hospitals & Clinics, Medical Device And Pharmaceutical Companies, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of hospital-acquired infection and growing number of surgical procedures that require high-intensity infection prevention

The global infection prevention and control market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.13% during the forecast period from 2024 to 2030. The demand for infection prevention and control is primarily being boosted by the increasing prevalence of increasing incidence of chronic diseases, the growing number of surgical procedures that require high-intensity infection prevention, growing figures of hospital-acquired infections, the rising number of government initiatives to ensure a high degree of infection prevention, growing healthcare industry, increasing product launches, and innovation in product development among others, thereby contribute to the overall growth of the infection prevention and control market during the forecast period from 2024-2030.

Infection Prevention And Control Market Dynamics:

The increasing prevalence of hospital-acquired infection globally is anticipated to bolster the market for hospital-acquired infection control during the forecasted period.

For instance, according to the World Health Organization (WHO) 2022, it was estimated that globally hundreds of millions of people every year are affected by healthcare-associated infections (HAIs), many of which are completely avoidable.

As per the same source, it was reported that out of every 100 patients, 7 patients are in high- and 15 patients in low or middle-income countries. WHO also concluded that globally, 1 in every 10 affected patients dies of a hospital-acquired infection.

From the above figures, it can be concluded that the prevalence of hospital-acquired infection is increasing globally. The increasing prevalence and mortality from the infection can be controlled by following proper measures such as maintaining proper hand hygiene, wearing masks, gloves, and other protective gear, disinfecting the area subjected to contamination, and following proper sterilization of all the equipment used in the hospitals; thereby increasing the demand of infection prevention and control products across the globe. Thus, the above factor will be responsible in propelling the overall market growth of infection prevention and control during the forecast period.

The rise in prevalence of chronic diseases like inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), peptic ulcer disease, Crohn's disease, diabetes, hypertension, cardiovascular disorders, cancer, and others due to environmental pollution, smoking, unhealthy lifestyles, poor nutrition and diet, and high intake of carcinogenic substances will drive the market of infection prevention and control product and devices.

For instance, according to the International Diabetes Federation, Diabetes Atlas 10th edition report 2021, globally 537 million adults (20-79 years) were living with diabetes in 2021. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. The rising prevalence of chronic disease will also increase the number of surgical procedures which in turn will increase the risk of infections. The transition of infections can be ceased by following proper sterilization and disinfectant techniques and also by using various infection prevention and control products such as hand or surface disinfectant, gloves, masks, and others.

Therefore, the rising number of surgical procedures owing to the rising prevalence of chronic disorders may increase the prevalence of hospital-acquired infections ultimately increasing the demand for infection prevention and control products.

In addition, government agencies are likely to play a larger role in the market's growth throughout the forecast period as they become more active in the issuance of guidelines aimed at raising global awareness of effective preventive measures. For example, the World Health Organization (WHO) has published guidelines for the healthcare industry's prevention and management of acute respiratory disorders that are susceptible to pandemics and epidemics. The recommendations cover anything from common sense safety measures like washing your hands often to using personal protective equipment and instructions for sterilizing and disinfecting.

Therefore, the above-mentioned factors will propel the infection prevention and control market during the forecast period from 2024-2030.

However, adverse effects of chemical disinfectants, stringent regulatory requirements with concerns for the safety of reprocessed instruments, and others may restrict the growth of the overall infection prevention and control market.

Infection Prevention And Control Market Segment Analysis:

Infection Prevention and Control Market by Product (Equipment [Sterilization Equipment {Heat Sterilization Equipment, Low-Temperature Sterilization Equipment, Radiation Sterilization, and Others} and Disinfectors {Washers, Flushes, Endoscope Reprocessors, and Others}] and Consumables [Disinfectants {Hand Disinfectants, Surface Disinfectants, Skin Disinfectants, and Others}, Personal Protective Equipment {Surgical Drapes, Surgical Gowns, Gloves, and Others}, Sterilization Consumables, Infectious Waste Disposal, and Others]), End-User (Hospitals & Clinics, Medical Device And Pharmaceutical Companies, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the infection prevention and control market, the hand disinfectants category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with the segment.

Hand disinfectants take very little time to kill the bacteria or viruses present on any surface. Additionally, hand disinfectants are generally nontoxic, non-irritating, inexpensive, and non-allergenic.

Hand disinfectants are easily portable therefore they can be used anywhere. It not only kills germs but prevents the transmission of germs from one person to another.

Further, alcohol-based hand disinfectants effectively reduce the bacterial counts on hands better than soap and water. Alcohol-based hand disinfectants are more effective against most bacteria and many viruses than either medicated or non-medicated soaps.

In addition, the usage of hand disinfectants was higher in hospitals during the pandemic as the number of hospitalizations increased during this time. The prime aim of hand disinfectants was to provide protection in healthcare facilities and safeguard personnel performing medical procedures that expose them to the virus.

Moreover, the product launches in the local market, in turn, drive the product demand in the market. For instance, in May 2020, Dukes India launched hand sanitizers, a type of hand disinfectant named Hand Safe, to help combat the COVID-19 virus.

Also, in June 2020, Cadila Pharmaceuticals launched a range of hand sanitizers, under the brand name Santiza and Laglo.

Therefore, owing to the above-mentioned factors, the hand disinfectants category is expected to register significant growth, thereby driving the growth of the overall infection prevention and control market during the forecast period.

North America is expected to dominate the overall Infection Prevention And Control Market:

Among all the regions, North America is estimated to account for the largest share of the infection prevention and control market in the year 2023. Owing to the significance of key growth factors such as the growing incidence of chronic diseases such as cancer, kidney disease, Crohn's disease, growing incidence of hospital-acquired infections and the high geriatric population, and high awareness about the advantages of proper infection prevention and control, consistent number of strategic collaborations, growing presence of outsourcing organizations, growing healthcare expenditure, unprecedented evolution of the healthcare standards and infrastructure, and others, the market for infection prevention and control is expected to witness prosperity in the region during the forecast period 2024-2030.

According to the Centers for Disease Control and Prevention (CDC), 2020 Annual National and State Healthcare-Associated Infections (HAI) Progress Report, it was estimated that between 2019 and 2020 in the United States, about 24% increase seen in central line-associated bloodstream infections (CLABSI) with the largest increase in infections transmitted from ICU.

The increasing prevalence of hospital-acquired infections will in turn increase the demand for infection prevention and control devices and consumables in the United States.

Further, a consistent number of strategic collaborations adopted by key market players to widen their product portfolio and infection control capabilities are believed to be responsible for the greater share captured by this region. For instance, In March 2023, Getinge completed the acquisition of Ultra Clean Systems Inc., a leading US manufacturer of ultrasonic cleaning technologies, used in hospitals and surgery centers to decontaminate surgical instruments. Ultrasonic cleaning is an integral part of best practices for reprocessing instruments, especially the most complex ones used for robotic surgery, to minimize the risk of hospital-acquired infections

Also, in March 2019, Getinge announced the US launch of a new 9100E Cart Washer. The 9100E Cart Washer represents the evolution of the company's successful 9100 series floor-loading cart and utensil washer-disinfectors. It was specifically designed to address the needs of hospitals, which require washers that have a reliable and sufficient throughput of a large variety of items that cannot be disinfected in a traditional instrument washer-disinfector, such as operating table transport trolleys, instrument containers, and other bulky items.

Thus, the above-mentioned factors are likely to propel the growth of the infection prevention and control market in the region during the forecast period from 2024-2030.

Infection Prevention And Control Market Key Players:

Some of the key market players operating in the infection prevention and control market include 3M, Fortive, Medivators Inc., Getinge AB, MELAG Medizintechnik GmbH & Co. KG, Metrex Research, LLC, MMM Group, STERIS, Sotera Health LLC, Nanosonics, BD, Owens & Minor, Matachana Group, Xenex Disinfection Services Inc., Ecolab, Bombayengg, Pal International, BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., Miele Group, Belimed AG, and others.

Recent Developmental Activities in the Infection Prevention And Control Market:

• In August 2021, Advanced Sterilization Products, a Fortive company, launched the STERRAD VELOCITY, a biological Indicator (BI)/process challenge device (PCD) in the Asia Pacific region.
• In June 2021, Nanosonics announced the launch of Nanosonics AuditPro, a new infection prevention digital product platform.
• In June 2021, STERIS plc completed the previously announced acquisition of Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis, and life sciences Customers.

Key Takeaways from the Infection Prevention And Control Market Report Study

• Market size analysis for current infection prevention and control market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global infection prevention and control market.
• Various opportunities available for the other competitors in the infection prevention and control market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current infection prevention and control market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for infection prevention and control market growth in the coming future?

Target Audience who can be benefited from this Infection Prevention And Control Market Report Study

• Infection prevention and control product providers
• Research organizations and consulting companies
• Infection prevention and control-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in infection prevention and control
• Various End-users who want to know more about the infection prevention and control market and the latest technological developments in the infection prevention and control market.

Frequently Asked Questions for the Infection Prevention And Control Market:

1. What is infection prevention and control?

Infection control products are concerned with the prevention or control of infection in healthcare settings, such as laboratories, hospitals, and others.

2. What is the market for global infection prevention and control?

The global infection prevention and control market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 6.13% during the forecast period from 2024 to 2030.

3. What are the drivers for the global infection prevention and control market?

The demand for infection prevention and control is primarily being boosted by the increasing incidence of hospital-acquired infections, the growing number of surgical procedures that require high-intensity infection prevention, the increasing incidence of chronic diseases along with the increasing geriatric population, increasing product launches, and others thereby contributing to the overall growth of the infection prevention and control market during the forecast period from 2024-2030.

4. Who are the key players operating in the global infection prevention and control market?

Some of the key market players operating in the infection prevention and control market include 3M, Fortive, Medivators Inc., Getinge AB, MELAG Medizintechnik GmbH & Co. KG, Metrex Research, LLC, MMM Group, STERIS, Sotera Health LLC, Nanosonics, BD, Owens & Minor, Matachana Group, Xenex Disinfection Services Inc., Ecolab, Bombayengg, Pal International, BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD., Miele Group, Belimed AG, and others.

5. Which region has the highest share in the infection prevention and control market?

North America is expected to dominate the overall infection prevention and control market during the forecast period from 2024-2030. Owing to factors such as the growing incidence of chronic diseases such as cancer, kidney disease, and Crohn's disease, the growing incidence of hospital-acquired infections and the high geriatric population, and high awareness about the advantages of proper infection prevention and control, a consistent number of strategic collaborations, growing presence of outsourcing organizations, growing healthcare expenditure, and unprecedented evolution of the healthcare standards and infrastructure, among others, the North America infection prevention and control market is expected to growth in coming years.

Table of Contents

1. Infection Prevention and Control Market Report Introduction

2. Infection Prevention and Control Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Infection Prevention and Control Market Key Factors Analysis

• 4.1. Infection Prevention and Control Market Drivers
  • 4.1.1. Increasing incidence of hospital-acquired infections
  • 4.1.2. Growing number of surgical procedures that require high-intensity infection prevention
  • 4.1.3. Increasing incidence of chronic diseases along with increasing geriatric population
• 4.2. Infection Prevention and Control Market Restraints and Challenges
  • 4.2.1. Adverse effects of chemical disinfectants
  • 4.2.2. Stringent regulatory requirements along with concerns for the safety of reprocessed instruments
• 4.3. Infection Prevention and Control Market Opportunities
  • 4.3.1. Increasing outsourcing of sterilization services
  • 4.3.2. Increasing adoption of disinfectant robots

5. Infection Prevention and Control Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Infection Prevention and Control Market Layout

• 6.1. By Product
  • 6.1.1. Equipment
    • 6.1.1.1. Sterilization Equipment
    • 6.1.1.1.1. Heat Sterilization Equipment
    • 6.1.1.1.2. Low-Temperature Sterilization Equipment
    • 6.1.1.1.3. Radiation Sterilization
    • 6.1.1.1.4. Other Products
    • 6.1.1.2. Disinfectors
    • 6.1.1.2.1. Washers
    • 6.1.1.2.2. Flushes
    • 6.1.1.2.3. Endoscope Reprocessors
    • 6.1.1.2.4. Others
  • 6.1.2. Consumables
    • 6.1.2.1. Disinfectants
    • 6.1.2.1.1. Hand Disinfectants
    • 6.1.2.1.2. Surface Disinfectants
    • 6.1.2.1.3. Skin Disinfectants
    • 6.1.2.1.4. Others
    • 6.1.2.2. Personal Protective Equipment
    • 6.1.2.2.1. Surgical Drapes
    • 6.1.2.2.2. Surgical Gowns
    • 6.1.2.2.3. Gloves
    • 6.1.2.2.4. Others
    • 6.1.2.3. Sterilization Consumables
    • 6.1.2.4. Infectious Waste Disposal
    • 6.1.2.5. Others
• 6.2. By End-User
  • 6.2.1. Hospitals & Clinics
  • 6.2.2. Medical Device and Pharmaceutical Companies
  • 6.2.3. Others
• 6.3. By Geography
  • 6.3.1. North America
    • 6.3.1.1. United States Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.1.2. Canada Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.1.3. Mexico Infection Prevention and Control Market Size in USD million (2021-2030)
  • 6.3.2. Europe
    • 6.3.2.1. France Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.2.2. Germany Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.2.3. United Kingdom Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.2.4. Italy Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.2.5. Spain Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.2.6. Rest of Europe Infection Prevention and Control Market Size in USD million (2021-2030)
  • 6.3.3. Asia-Pacific
    • 6.3.3.1. China Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.3.2. Japan Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.3.3. India Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.3.4. Australia Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.3.5. South Korea Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.3.6. Rest of Asia-Pacific Infection Prevention and Control Market Size in USD million (2021-2030)
  • 6.3.4. Rest of the World (RoW)
    • 6.3.4.1. Middle East Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.4.2. Africa Infection Prevention and Control Market Size in USD million (2021-2030)
    • 6.3.4.3. South America Infection Prevention and Control Market Size in USD million (2021-2030)

7. Infection Prevention and Control Market Company and Product Profiles

• 7.1. 3M
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Fortive
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Medivators Inc
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Getinge AB
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. MELAG Medizintechnik GmbH & Co. KG
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Metrex Research, LLC
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. MMM Group
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. STERIS
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Sotera Health LLC
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Nanosonics
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. BD
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Owens & Minor
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Matachana Group
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. Xenex Disinfection Services Inc.
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Ecolab
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy
• 7.16. bombayengg
  • 7.16.1. Company Overview
  • 7.16.2. Company Snapshot
  • 7.16.3. Financial Overview
  • 7.16.4. Product Listing
  • 7.16.5. Entropy
• 7.17. Pal International
  • 7.17.1. Company Overview
  • 7.17.2. Company Snapshot
  • 7.17.3. Financial Overview
  • 7.17.4. Product Listing
  • 7.17.5. Entropy
• 7.18. BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD.
  • 7.18.1. Company Overview
  • 7.18.2. Company Snapshot
  • 7.18.3. Financial Overview
  • 7.18.4. Product Listing
  • 7.18.5. Entropy
• 7.19. Miele Group
  • 7.19.1. Company Overview
  • 7.19.2. Company Snapshot
  • 7.19.3. Financial Overview
  • 7.19.4. Product Listing
  • 7.19.5. Entropy
• 7.20. Belimed AG
  • 7.20.1. Company Overview
  • 7.20.2. Company Snapshot
  • 7.20.3. Financial Overview
  • 7.20.4. Product Listing
  • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us